Your browser doesn't support javascript.
COVLIAS 1.0: Lung Segmentation in COVID-19 Computed Tomography Scans Using Hybrid Deep Learning Artificial Intelligence Models.
Suri, Jasjit S; Agarwal, Sushant; Pathak, Rajesh; Ketireddy, Vedmanvitha; Columbu, Marta; Saba, Luca; Gupta, Suneet K; Faa, Gavino; Singh, Inder M; Turk, Monika; Chadha, Paramjit S; Johri, Amer M; Khanna, Narendra N; Viskovic, Klaudija; Mavrogeni, Sophie; Laird, John R; Pareek, Gyan; Miner, Martin; Sobel, David W; Balestrieri, Antonella; Sfikakis, Petros P; Tsoulfas, George; Protogerou, Athanasios; Misra, Durga Prasanna; Agarwal, Vikas; Kitas, George D; Teji, Jagjit S; Al-Maini, Mustafa; Dhanjil, Surinder K; Nicolaides, Andrew; Sharma, Aditya; Rathore, Vijay; Fatemi, Mostafa; Alizad, Azra; Krishnan, Pudukode R; Frence, Nagy; Ruzsa, Zoltan; Gupta, Archna; Naidu, Subbaram; Kalra, Mannudeep.
  • Suri JS; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Agarwal S; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Pathak R; Advanced Knowledge Engineering Centre, GBTI, Roseville, CA 95661, USA.
  • Ketireddy V; Department of Computer Science Engineering, PSIT, Kanpur 209305, India.
  • Columbu M; Department of Computer Science Engineering, Rawatpura Sarkar University, Raipur 492015, India.
  • Saba L; Mira Loma High School, Sacramento, CA 95821, USA.
  • Gupta SK; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy.
  • Faa G; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy.
  • Singh IM; Department of Computer Science, Bennett University, Noida 201310, India.
  • Turk M; Department of Pathology-AOU of Cagliari, 09124 Cagliari, Italy.
  • Chadha PS; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Johri AM; The Hanse-Wissenschaftskolleg Institute for Advanced Study, 27753 Delmenhorst, Germany.
  • Khanna NN; Stroke Diagnostic and Monitoring Division, AtheroPoint™, Roseville, CA 95661, USA.
  • Viskovic K; Department of Medicine, Division of Cardiology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Mavrogeni S; Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi 208011, India.
  • Laird JR; Department of Radiology, University Hospital for Infectious Diseases, 10000 Zagreb, Croatia.
  • Pareek G; Cardiology Clinic, Onassis Cardiac Surgery Center, 176 74 Athens, Greece.
  • Miner M; Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA 94574, USA.
  • Sobel DW; Minimally Invasive Urology Institute, Brown University, Providence City, RI 02912, USA.
  • Balestrieri A; Men's Health Center, Miriam Hospital Providence, Providence, RI 02906, USA.
  • Sfikakis PP; Minimally Invasive Urology Institute, Brown University, Providence City, RI 02912, USA.
  • Tsoulfas G; Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), 09124 Cagliari, Italy.
  • Protogerou A; Rheumatology Unit, National Kapodistrian University of Athens, 157 72 Athens, Greece.
  • Misra DP; Department of Transplantation Surgery, Aristoteleion University of Thessaloniki, 541 24 Thessaloniki, Greece.
  • Agarwal V; National & Kapodistrian University of Athens, 157 72 Athens, Greece.
  • Kitas GD; Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
  • Teji JS; Department of Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.
  • Al-Maini M; Academic Affairs, Dudley Group NHS Foundation Trust, Dudley DY1 2HQ, UK.
  • Dhanjil SK; Arthritis Research UK Epidemiology Unit, Manchester University, Manchester M13 9PL, UK.
  • Nicolaides A; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
  • Sharma A; Allergy, Clinical Immunology and Rheumatology Institute, Toronto, ON M5G 1N8, Canada.
  • Rathore V; Athero Point LLC, Roseville, CA 95611, USA.
  • Fatemi M; Vascular Screening and Diagnostic Centre, University of Nicosia Medical School, Nicosia 2408, Cyprus.
  • Alizad A; Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA 22904, USA.
  • Krishnan PR; Athero Point LLC, Roseville, CA 95611, USA.
  • Frence N; Department of Physiology & Biomedical Engg., Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Ruzsa Z; Department of Radiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
  • Gupta A; Neurology Department, Fortis Hospital, Bangalore 560076, India.
  • Naidu S; Department of Internal Medicines, Invasive Cardiology Division, University of Szeged, 6720 Szeged, Hungary.
  • Kalra M; Department of Internal Medicines, Invasive Cardiology Division, University of Szeged, 6720 Szeged, Hungary.
Diagnostics (Basel) ; 11(8)2021 Aug 04.
Article in English | MEDLINE | ID: covidwho-1341653
ABSTRACT

BACKGROUND:

COVID-19 lung segmentation using Computed Tomography (CT) scans is important for the diagnosis of lung severity. The process of automated lung segmentation is challenging due to (a) CT radiation dosage and (b) ground-glass opacities caused by COVID-19. The lung segmentation methodologies proposed in 2020 were semi- or automated but not reliable, accurate, and user-friendly. The proposed study presents a COVID Lung Image Analysis System (COVLIAS 1.0, AtheroPoint™, Roseville, CA, USA) consisting of hybrid deep learning (HDL) models for lung segmentation.

METHODOLOGY:

The COVLIAS 1.0 consists of three methods based on solo deep learning (SDL) or hybrid deep learning (HDL). SegNet is proposed in the SDL category while VGG-SegNet and ResNet-SegNet are designed under the HDL paradigm. The three proposed AI approaches were benchmarked against the National Institute of Health (NIH)-based conventional segmentation model using fuzzy-connectedness. A cross-validation protocol with a 4060 ratio between training and testing was designed, with 10% validation data. The ground truth (GT) was manually traced by a radiologist trained personnel. For performance evaluation, nine different criteria were selected to perform the evaluation of SDL or HDL lung segmentation regions and lungs long axis against GT.

RESULTS:

Using the database of 5000 chest CT images (from 72 patients), COVLIAS 1.0 yielded AUC of ~0.96, ~0.97, ~0.98, and ~0.96 (p-value < 0.001), respectively within 5% range of GT area, for SegNet, VGG-SegNet, ResNet-SegNet, and NIH. The mean Figure of Merit using four models (left and right lung) was above 94%. On benchmarking against the National Institute of Health (NIH) segmentation method, the proposed model demonstrated a 58% and 44% improvement in ResNet-SegNet, 52% and 36% improvement in VGG-SegNet for lung area, and lung long axis, respectively. The PE statistics performance was in the following order ResNet-SegNet > VGG-SegNet > NIH > SegNet. The HDL runs in <1 s on test data per image.

CONCLUSIONS:

The COVLIAS 1.0 system can be applied in real-time for radiology-based clinical settings.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11081405

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11081405